TUESDAY, SEPTEMBER 26, 2017 5:30 PM - 9:00 PM
STATE OF THE SCIENCE SUMMIT: ADVANCED NON-SMALL CELL LUNG CANCER
TUESDAY, SEPT EMBE R 26, 2017 5: 30 P M - 9: 00 P M LOCATION: JW Marriott Chicago 151 W Adams Street Chicago, IL 60603
PROGRAM CHAIR: Mary Jo Fidler, MD
Presentations By: Lawrence Feldman, MD
TOPICS OF DISCUSSION:
Jyoti Patel, MD Victoria Villaflor, MD
• Biomarkers in NSCLC • Checkpoint inhibition in first-line and second-line therapy and beyond • Combination Strategies with Immunotherapy • Targeted Therapies: EGFR, sequencing • Targeted Therapies: ALK, ROS1, sequencing • New targetable drivers – the case for next generation sequencing
Thomas Hensing, MD To register, please contact Allison Cooper at: [email protected] or visit: www.onclive.com/meetings/soss
TUESDAY, SEPT EMBE R 26, 2017 5: 30 P M - 9: 00 P M LOCATION: JW Marriott Chicago 151 W Adams Street Chicago, IL 60603
PROGRAM CHAIR: Mary Jo Fidler, MD
Presentations By: Lawrence Feldman, MD
TOPICS OF DISCUSSION:
Jyoti Patel, MD Victoria Villaflor, MD
• Biomarkers in NSCLC • Checkpoint inhibition in first-line and second-line therapy and beyond • Combination Strategies with Immunotherapy • Targeted Therapies: EGFR, sequencing • Targeted Therapies: ALK, ROS1, sequencing • New targetable drivers – the case for next generation sequencing
Thomas Hensing, MD To register, please contact Allison Cooper at: [email protected] or visit: www.onclive.com/meetings/soss
